Super-resolution imaging reveals the evolution of higher-order chromatin folding in early carcinogenesis

Jianquan Xu, Hongqiang Ma, Hongbin Ma, Wei Jiang, Christopher A. Mela, Mei-Han Duan, Shimei Zhao, Chenxi Gao, Eun‐Ryeong Hahm, Santana M. Lardo, Kris Troy, Ming Sun, Reet Pai, Donna B. Stolz, Lin Zhang, Shivendra V. Singh, Randall E. Brand, Douglas J. Hartman, Jing Hu, Sarah J. Hainer, Yang Liu

Abstract

Genomic DNA is folded into a higher-order structure that regulates transcription and maintains genomic stability. Although progress has been made on understanding biochemical characteristics of epigenetic modifications in cancer, the in-situ higher-order folding of chromatin structure during malignant transformation remains largely unknown. Here, using optimized stochastic optical reconstruction microscopy (STORM) for pathological tissue (PathSTORM), we uncover a gradual decompaction and fragmentation of higher-order chromatin folding throughout all stages of carcinogenesis in multiple tumor types, and prior to tumor formation. Our integrated imaging, genomic, and transcriptomic analyses reveal functional consequences in enhanced transcription activities and impaired genomic stability. We also demonstrate the potential of imaging higher-order chromatin disruption to detect high-risk precursors that cannot be distinguished by conventional pathology. Taken together, our findings reveal gradual decompaction and fragmentation of higher-order chromatin structure as an enabling characteristic in early carcinogenesis to facilitate malignant transformation, which may improve cancer diagnosis, risk stratification, and prevention.

Introduction

In healthy cells, DNA is meticulously packaged into a 3D architecture known as chromatin. This higher-order folding is not merely a storage solution; it is a critical regulatory mechanism that governs gene expression and preserves genomic integrity. While the biochemical aspects of cancer—such as epigenetic modifications—are well-studied, the physical structural changes of chromatin during the transition from healthy to malignant states have remained largely elusive.

The primary obstacle has been the diffraction limit of conventional light microscopy, which cannot resolve features smaller than approximately 250 nm. Since the fundamental units of chromatin organization, such as nucleosome clusters, operate at the 30–100 nm scale, the early "structural collapse" of DNA during carcinogenesis has been invisible to standard pathology. This study introduces a novel super-resolution imaging approach to visualize and quantify these nanoscale alterations in clinical tissue samples.

Methods and Materials

The researchers developed PathSTORM, an optimized version of Stochastic Optical Reconstruction Microscopy (STORM) tailored for formalin-fixed paraffin-embedded (FFPE) pathological tissues. To overcome the high background noise and light scattering of thick clinical sections, the team implemented optical clearing and index matching. Furthermore, they utilized extreme-value-based algorithms for advanced emitter recovery, allowing for precise single-molecule localization despite high autofluorescence.

The study employed a diverse range of models, including:

  • Animal Models: Intestinal ($Apc^{Min/+}$), prostate (Hi-MYC), and pancreatic ($Kras^{G12D/+}$) cancer models.
  • Human Clinical Samples: 19 samples spanning the progression of colorectal neoplasia, from normal tissue to adenocarcinoma.
  • Integrated Analysis: Nanoscale imaging was combined with CUT&RUN and RNA-seq to correlate physical structural changes with functional genomic and transcriptomic outcomes.

Results

PathSTORM achieved a lateral resolution of ~30 nm, enabling the visualization of chromatin architecture that is otherwise hidden. A key finding is that chromatin undergoes a progressive process of physical decompaction and fragmentation during the earliest stages of cancer.

PathSTORM imaging reveals the progressive decompaction of chromatin from wild-type to adenoma stages in the ApcMin/+ mouse model.

As shown in Figure 3, cells that appear histologically normal under standard H&E staining already exhibit significant chromatin disruption if they are at high risk for tumor formation—a phenomenon known as the "field effect." This structural breakdown is most prominent at satellite repeats, which are essential for chromosome stability.

Quantitatively, the study observed a steady decline in the size of DNA nanodomains as carcinogenesis progressed. In the $Apc^{Min/+}$ mouse model, nanodomain size decreased from approximately 200 nm in wild-type cells to roughly 160 nm in tumor cells.

Bar chart showing the significant and gradual decrease in DNA nanodomain size across different stages of carcinogenesis.

These physical changes have direct functional consequences. The fragmentation of chromatin creates "open" regions that facilitate aberrant increases in transcription (measured by RNA Polymerase II activity) and lead to higher rates of DNA double-strand breaks, thereby driving genomic instability.

Discussion and Clinical Implications

The discovery that chromatin disruption is a gradual "unravelling" process rather than a sudden event suggests that nanoscale imaging could serve as a powerful tool for early risk stratification. PathSTORM successfully distinguished between low-risk and high-risk precursor lesions that appeared identical under conventional microscopy.

However, several challenges remain before clinical adoption. Super-resolution imaging is currently more time-consuming and technically complex than standard staining methods. Additionally, while the results in the 19-patient human cohort are promising, larger studies are required to validate these structural changes as definitive biomarkers. Future research should also investigate the causal relationship: could stabilizing chromatin structure prevent or stall the progression of early-stage cancer?

In conclusion, the gradual decompaction and fragmentation of higher-order chromatin structure represent an enabling characteristic of early carcinogenesis. By revealing these previously invisible changes, PathSTORM offers a new frontier for cancer diagnosis and prevention.

Summary updated

Abstract

Genomic DNA is folded into a higher-order structure that regulates transcription and maintains genomic stability. Although progress has been made on understanding biochemical characteristics of epigenetic modifications in cancer, the in-situ higher-order folding of chromatin structure during malignant transformation remains largely unknown. Here, using optimized stochastic optical reconstruction microscopy (STORM) for pathological tissue (PathSTORM), we uncover a gradual decompaction and fragmentation of higher-order chromatin folding throughout all stages of carcinogenesis in multiple tumor types, and prior to tumor formation. Our integrated imaging, genomic, and transcriptomic analyses reveal functional consequences in enhanced transcription activities and impaired genomic stability. We also demonstrate the potential of imaging higher-order chromatin disruption to detect high-risk precursors that cannot be distinguished by conventional pathology. Taken together, our findings reveal gradual decompaction and fragmentation of higher-order chromatin structure as an enabling characteristic in early carcinogenesis to facilitate malignant transformation, which may improve cancer diagnosis, risk stratification, and prevention.
BibTeX
@inproceedings{xu2020super,
  author = {Jianquan Xu and Hongqiang Ma and Hongbin Ma and Wei Jiang and Christopher A. Mela and Mei-Han Duan and Shimei Zhao and Chenxi Gao and Eun‐Ryeong Hahm and Santana M. Lardo and Kris Troy and Ming Sun and Reet Pai and Donna B. Stolz and Lin Zhang and Shivendra V. Singh and Randall E. Brand and Douglas J. Hartman and Jing Hu and Sarah J. Hainer and Yang Liu},
  title = {{Super-resolution imaging reveals the evolution of higher-order chromatin folding in early carcinogenesis}},
  booktitle = {Nature Communications},
  year = {2020},
  doi = {10.1038/s41467-020-15718-7},
}
Figure